As part of a suite of jaundice diagnostic and treatment technologies aimed at ending kernicterus, we have developed Comet, an extremely low-cost, high-performance, and compact jaundice treatment device targeted at rural and limited-infrastructure clinics and hospitals in developing countries. Comet integrates low power consumption and high intensity LEDs with a lifespan of 3-5 years to provide phototherapy on par with state-of-the-art devices. However, Comet requires minimal maintenance and is designed to retail at less than $150. In partnership with One Heart World-Wide, we are seeking seed funding to field test Comet in India and Nepal, refine the design for final embodiment, and begin market and delivery development.
More information about Saving Lives at Birth (Round 2)